Previous 10 | Next 10 |
2023-05-11 22:33:08 ET Co-Diagnostics, Inc. (CODX) Q1 2023 Earnings Conference Call May 11, 2023 16:30 ET Company Participants Andrew Benson - Head, Investor Relations Dwight Egan - Chief Executive Officer Brian Brown - Chief Financial Officer Conference Ca...
2023-05-11 16:02:14 ET Co-Diagnostics press release ( NASDAQ: CODX ): Q1 GAAP EPS of -$0.20 beats by $0.03 . Revenue of $0.61M (-97.3% Y/Y) misses by $0.49M . For further details see: Co-Diagnostics GAAP EPS of -$0.20 beats by $0.03, revenue of $0.61M mis...
Co-Diagnostics, Inc. Reports First Quarter 2023 Financial Results PR Newswire Clinical trials for Co-Dx PCR Home™ platform remain on track; Solid cash position and grant funding support long-term strategy SALT LAKE CITY , May 11, 2023 /PRNe...
2023-05-11 14:12:03 ET Following a meeting of its expert advisors, the World Health Organization announced Thursday that the monkeypox outbreak would no longer be regarded as a public health emergency of international concern (PHEIC). Monkeypox virus, currently known as mpox, led to a g...
Co-Diagnostics, Inc. to Host Booth at Senior Living Executive Conference in New Orleans, LA PR Newswire SALT LAKE CITY , May 9, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a u...
Co-Diagnostics, Inc. to Host Booth at 67th Annual CARPHA Conference April 27-29 PR Newswire SALT LAKE CITY , April 26, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented...
2023-04-18 17:26:02 ET Summary After one month, the coffee can small cap portfolio has 14 stocks up and 12 stocks down. The biggest gainer over one month was JAKKS Pacific with a 45.8% gain. The biggest drag was Co-Diagnostics with a 43.66% decrease. The coffee can p...
Co-Diagnostics, Inc. to Host Booth at ECCMID 2023 April 15-18 in Copenhagen, Denmark PR Newswire SALT LAKE CITY , April 13, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a uniqu...
Co-Diagnostics, Inc. to CEO to Deliver Keynote Address at 2023 MarketsandMarkets Conference in London, England PR Newswire SALT LAKE CITY , March 21, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics...
2023-03-20 15:16:50 ET Co-Diagnostics ( NASDAQ: CODX ) extended the selloff for the second straight session on Monday as H.C. Wainwright downgraded the COVID-19 test maker and halved its price target, citing lower-than-expected Q4 results. The analyst Yi Chen notes that ...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago PR Newswire SALT LAKE CITY , July 29, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company wi...
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , July 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States PR Newswire SALT LAKE CITY , July 2, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company w...